Xtant Medical

Quarterly Financials

Values in thousands 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue
$31,513
$27,937
$29,943
$27,873
Gross Profit
16,024
16,307
18,582
17,302
EBITDA
-862
-2,690
-1,835
-2,492
EBIT
-2,010
-3,763
-2,833
-3,496
Net Income
-3,165
-5,024
-3,861
-4,400
Net Change In Cash
31,513
27,937
29,943
27,873
Free Cash Flow
-7
-3,822
-5,652
-6,528
Cash
6,199
6,596
5,379
4,624
Basic Shares
133,665
135,100
130,269
130,201

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$117,267
$91,303
$57,969
$55,263
Gross Profit
68,216
55,467
32,137
32,490
EBITDA
-12,074
5,074
-5,428
-2,513
EBIT
-12,102
1,900
-6,724
-3,854
Net Income
-16,449
660
-8,485
-5,844
Net Change In Cash
117,267
91,303
57,969
55,263
Cost of Revenue
2,120
Free Cash Flow
-16,009
-10,971
-7,105
-1,676
Cash
6,199
5,715
20,298
18,243
Basic Shares
133,665
126,793
94,085
85,456

Earnings Calls

Quarter EPS
2024-12-31
-$0.01
2024-09-30
-$0.04
2024-06-30
-$0.03
2024-03-31
-$0.03